AMERICAN JOURNAL OF SURGICAL PATHOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2025-02-28 我恨梅斯Medsci 来自香港

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：恶性肿瘤;罕见病;病理
经验分享：2025年2月13日投稿；
2025年2月17日邮件告知有两个figures格式不符合；
2025年2月18日更改figures格式后重新提交；
2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor;
.................

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2022-09-03 马得得得得得

投稿命中率:50.0
经验分享：04-14:submit
04-16:assign the number
05-20:revise major
07-06:revise minor
07-20:accept
08-26:publish
期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。

120 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2022-11-17 高如月

请问要每个作者都通过邮箱确认才能审稿吗？

135 0

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2022-04-18 ms6000000370940246

请问要每个作者都通过邮箱确诊才能审稿吗

137 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2021-12-28 Gym璨烨

researcharticle是什么意思？

143 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2021-12-27 MS54455111222

什么是letter?

128 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2018-10-12 ms6267360147337765

审稿速度:2.0 | 投稿命中率:25.0
经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中

223 0

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2017-07-16 yangbin2015

过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了.

459 0

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2016-01-31 bolt614

审稿速度:1.0 | 投稿命中率:25.0
经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。

306 0

[GetPortalCommentsPageByObjectIdResponse(id=2253930, encodeId=7b3f22539309f, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：恶性肿瘤;罕见病;病理 经验分享：2025年2月13日投稿； 2025年2月17日邮件告知有两个figures格式不符合； 2025年2月18日更改figures格式后重新提交； 2025年2月28日邮件告知分配manuscript number，投稿页面显示with editor; ................., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c665384789, createdName=我恨梅斯Medsci, createdTime=Fri Feb 28 00:52:35 CST 2025, time=2025-02-28, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=1242909, encodeId=af9d1242909cb, content=投稿命中率:50.0 经验分享：04-14:submit 04-16:assign the number 05-20:revise major 07-06:revise minor 07-20:accept 08-26:publish 期间大修因为个人原因耽误了一段时间，总体速度还是很快的，这个杂志和审稿人都偏病理，涉及很多病理的细节问题，编辑很友好，体验五颗星。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=马得得得得得, createdTime=Sat Sep 03 08:42:43 CST 2022, time=2022-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101222, encodeId=18ee2101222ba, content=请问要每个作者都通过邮箱确认才能审稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLBia25PUps4TUicRic270sllcIRF5caJuNoZFp1IvEtzMmkricn8DibzoibpOpxJu8pmibnI61Cjda7ZJgA/132, createdBy=27c42509136, createdName=高如月, createdTime=Thu Nov 17 23:24:05 CST 2022, time=2022-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212107, encodeId=cc80121210e0b, content=请问要每个作者都通过邮箱确诊才能审稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220418/992fbbf9d6d24085909656cadd40b1ee/3f54d106eb1c44e4b62bbbe48193abc1.jpeg, createdBy=8d8c5505259, createdName=ms6000000370940246, createdTime=Mon Apr 18 09:47:57 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086533, encodeId=ec1d1086533e3, content=researcharticle是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086534, encodeId=08071086534fa, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847661, encodeId=d74384e66130, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：非常看好这个期刊，近两年都是的文章质量都挺高，今年也试试投一篇，看看是否可能中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f34b5414151, createdName=ms6267360147337765, createdTime=Fri Oct 12 17:51:30 CST 2018, time=2018-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544150, encodeId=3aaf544150fa, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=459, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518920, encodeId=768551892005, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：杂志很专业，由于之前头综合类杂志被拒稿。审稿人很认真，编辑很负责速度很快。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=96701678023, createdName=bolt614, createdTime=Sun Jan 31 00:12:00 CST 2016, time=2016-01-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503230, encodeId=ea02503230a6, content=2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=539, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a2e7100761, createdName=littlestone, createdTime=Thu May 29 16:11:00 CST 2014, time=2014-05-29, status=1, ipAttribution=)]

2014-05-29 littlestone

2011年一篇投Journal of Hepatology修回后被拒，投AJP接收，当然改动也不小

539 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务